We next confirmed the results in the clinical context through the comparison between control thymocytes and T-ALL samples with JAK/STAT pathway mutations and elevated PIM1 expression (Supplementary Fig. 4a), further supporting the relevance of PIM1 activity for the mRNA expression of specific gene sets. The gene discussed is PIM1; the disease is acute lymphoblastic leukemia.